Navigation Links
AHRQ Announces Guide to Help Patients on Coumadin(R)/Warfarin Therapy
Date:5/22/2008

ROCKVILLE, Md., May 22 /PRNewswire-USNewswire/ -- The U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality today released a new consumer publication, Your Guide to Coumadin(R)/Warfarin Therapy. This 20-page, easy-to-read patient brochure explains what patients should expect and watch out for while undergoing Coumadin(R)/warfarin therapy.

In 2005, more than 3.8 million Americans were taking Coumadin(R)/warfarin at an estimated cost of nearly $963 million, according to the latest data from AHRQ. Warfarin is a blood thinner that is used to help prevent blood clots that can cause a stroke, heart attack or other serious conditions. Clinicians sometimes prescribe it for other uses as well, and the booklet is intended to help patients who have been prescribed the drug to use it as safely as possible. Warfarin is the second most common drug -- after insulin -- implicated in emergency room visits for adverse drug events, according to HHS' Food and Drug Administration.

"Warfarin is an effective drug, but it must be used with special care to avoid dangerous bleeding," said AHRQ Director Carolyn M. Clancy, M.D. "Individuals respond differently to warfarin, so the dosage must be personalized to each patient, and it is necessary for patients and clinicians alike to be aware of the factors that make for safe use of the drug."

A simple blood test can quickly tell whether a patient is taking too much or too little warfarin. This brochure educates patients about their medication therapy and potentially dangerous side effects, explains how to communicate effectively with their health care providers and provides tips for lifestyle modifications. It also provides information on remembering when to take the medicine, learning how to stay safe while taking the medicine, maintaining a consistent diet and alerting health care providers to concurrent drugs and/or supplements patients are taking to avoid any potential adverse interactions.

This publication was developed through one of AHRQ's Partnership for Implementing Patient Safety (PIPS) grant projects at Kirkwood Community College. The project was led by James Levett, M.D., Chief Medical Officer at the Physicians Clinic of Iowa and Carla Huber, A.R.N.P., M.S., of the Cedar Rapids Healthcare Alliance. The purpose of PIPS grants is to assist consumers, clinicians and health care institutions in implementing safe practices that may eliminate or reduce medical errors, risks, hazards and harms associated with health care processes.

The new booklet can be found online at http://www.ahrq.gov/consumer/coumadin.htm. It is also featured on the SOS Rx Coalition's Web site http://www.mybloodthinner.org. Free single copies of Your Guide to Coumadin(R)/Warfarin Therapy are available by calling the AHRQ Publications Clearinghouse at (800) 358-9295 or by sending an e-mail to AHRQPubs@ahrq.hhs.gov.


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. JDRF announces 2008 Spring Research Review Award
2. SPO Medical Announces Entry into the Global Baby Monitor Consumer Market
3. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
4. STOP Obesity Alliance Announces New Research Indicating That Employers Want to Address Obesity in the Workplace, Need More Guidance
5. China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
6. Worcester Polytechnic Institute announces 2008 Chairmans Exemplary Faculty Prize winners
7. Lilly Announces Changes in Key Leadership Roles
8. China Holdings Announces Development on TaiHu and Ongniute Biomass Power Plants/Projects
9. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
10. Crdentia Announces 2008 First Quarter Results
11. AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Today, Our Urgent Care ... with a public ribbon cutting ceremony. Since opening over a month ago, ... to the emergency room. The new Our Urgent Care walk-in clinic is located ...
(Date:5/22/2017)... ... ... Galena, Alaska, has a population of less than 500 people. But, the ... to build a nuclear plant by the TOSHIBA Corporation. , In “The Galena Nuclear ... the journey to get power to his small town, off the electrical grid. , ...
(Date:5/22/2017)... ... May 22, 2017 , ... OSF Ventures, ... investing in InsightRX, an early stage company in San Francisco that has developed ... Greatpoint Ventures Innovation Fund acted as the lead investor in the ...
(Date:5/21/2017)... ... May 20, 2017 , ... GetLinked® software ... and financial systems. , Dozens of clubs using ABC Financial Services are ... through GetLinked into their club’s accounting system , The latest implementation is ...
(Date:5/21/2017)... ... May 21, 2017 , ... For the past 10 ... of scholars, policymakers, and activists wanting to address equity issues in breastfeeding, and ... third book from a recent series of from this conference. , The ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 4, 2017  A recent study published in ... Ultraviolet-C light as a means of disinfection anesthesia ... reduce bioburden on anesthesia workstations. In the study, ... complex medical equipment surfaces contaminated with three (3) ... "This study further validates the body of literature ...
(Date:5/4/2017)... May 4, 2017  A new tight-tolerance microextrusion ... other highly-engineered materials, is being launched by Natvar, ... been developed in recent years to service a ... surgical applications. More expensive materials such as glass ... tubing due to their ability to consistently hold ...
(Date:5/3/2017)...  Getinge, a leading global provider of products ... cost efficiency within healthcare and life sciences, today ... demonstrating that intra-aortic balloon counterpulsation (IABC) appears effective ... The single-center, retrospective, observational study showed that use ... 50cc intra-aortic balloon (IAB) in contemporary practice ...
Breaking Medicine Technology: